Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has J. Doyen's publication output changed over time?
ScholarIQpublication output · 2008–2025
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2025.
1
1
1
1
1
1
1
1
1
1
2008200920112013201420162017201820202025
What are the most-cited papers on J. Doyen?
ScholarIQmost cited works
Prognostic factors in 1038 women with metastatic breast cancer
R. Largillier, Jean-Marc Ferrero, J. Doyen, Jérôme Barrière, M. Namer, Véronique Mari, A. Courdi, Jean‐Michel Hannoun‐Lévi, F. Ettore, Isabelle Birtwisle‐Peyrottes, C. Balu–Maestro, Pierre Yves Marcy, I. Raoust, M. Lallement, Emmanuel Chamorey
Annals of Oncology. 2008380 CitationsOPEN ACCESS
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
Sébastien Grosso, J. Doyen, Scott K. Parks, Thomas Bertero, Alexandra Paye, Bruno Cardinaud, Pierre Gounon, Sandra Lacas‐Gervais, Agnès Noël, Jacques Pouysségur, Pascal Barbry, Nathalie M. Mazure, Bernard Mari
Cell Death and Disease. 2013214 CitationsOPEN ACCESS
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome
J. Doyen, C. Trastour, F. Ettore, Isabelle Peyrottes, N. Toussant, Jocelyn Gal, Karine Ilc, Damien Roux, Scott K. Parks, Jean-Marc Ferrero, Jacques Pouysségur
Biochemical and Biophysical Research Communications. 2014114 CitationsOPEN ACCESS
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Carine El Sissy, Amos Kirilovsky, Marc Van den Eynde, Ana-Maria Mușină, Maria-Gabriela Aniței, Alfredo Romero, Florence Marliot, Audelaure Junca, J. Doyen, Bernhard Mlecnik, Nacilla Haicheur, Tessa Fredriksen, Christine Lagorce, Anne Jouret‐Mourin, Daniel Léonard, Frédéric Bibeau, Soledad Iseas, Enrique Roca, Ana Cabanne, Carlos Vaccaro, Juan Pablo Santino, Eduardo Huertas, David Tougeron, Carlos Carvalho, Nuno Figueiredo, Rodrigo Oliva Perez, Angelita Habr‐Gama, Viorel Scripcariu, Jean‐Pierre Gérard, Jérôme Galon, Guy Zeitoun, Franck Pagès
Clinical Cancer Research. 2020110 CitationsOPEN ACCESS
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
D. Azria, J. Doyen, Marta Jarlier, Isabelle Martel‐Lafay, Christophe Hennequin, Pierre-Luc Etienne, V. Vendrely, Éric François, G. Roche, Olivier Bouché, X. Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, Marc-André Mahé, Y. Bécouarn, Olivier Dupuis, Gérard Lledo, Jean‐François Seitz, Laurent Bedenne, S. Gourgou-Bourgade, Béata Juzyna, Thierry Conroy, J.P. Gérard
Annals of Oncology. 2017106 CitationsOPEN ACCESS
Related on ScholarIQ
Institut de Recherche sur le Cancer et le Vieillissement de Nice
Institution
Prognostic factors in 1038 women with metastatic breast cancer
Paper
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
Paper
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome
Paper
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Paper
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
Paper